ISSN: 2095-1264

Journal Home

Journal Guideline

Anti-Tumor Pharmacy Q4 Unclaimed

0 China

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Anti-Tumor Pharmacy is a journal indexed in SJR in Oncology and Pharmaceutical Science with an H index of 1. It has an SJR impact factor of 0,101 and it has a best quartile of Q4. It has an SJR impact factor of 0,101.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Oncology (Q4) Pharmaceutical Science (Q4) Pharmacology (medical) (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,101

SJR Impact factor

1

H Index

0

Total Docs (Last Year)

24

Total Docs (3 years)

0

Total Refs

1

Total Cites (3 years)

24

Citable Docs (3 years)

0

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Experimental Oncology Q4
Psicooncologia Q4
Klinicka Onkologie Q4
Current Cancer Therapy Reviews Q4
Journal of Radiotherapy in Practice Q4

Compare this journals

Anti-Tumor Pharmacy Q4 Unclaimed

- €

NPD

- €

Metrics

0,101

1

0

24

0

1

24

0

0.0

Comments

Other journals with similar parameters

Aims and Scope

FAQS

What is the impact factor of Anti-Tumor Pharmacy?